Skip to content

Obesity

More articles from IG:
IG Spread betting and CFD Trading

Macro Intelligence: weight-loss drugs drive big pharma

After an initial negative reaction to the weight-loss drug thematic, ResMed says the trend will boost demand for its products. However, with alcohol consumption amongst GLP-1 patients waning, beverage companies could suffer.

Wednesday 08 May 2024 00:11